CTMX: CytomX Therapeutics Inc. Stocks News on November 24, 2024

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

CTMX

Zacks

3 days ago

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

CTMX

Zacks

4 days ago

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

CTMX

Zacks

5 days ago

Down -25.59% in 4 Weeks, Here's Why CytomX Therapeutics (CTMX) Looks Ripe for a Turnaround

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

CTMX

Zacks

5 days ago

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

CytomX Therapeutics Third Quarter 2024 Earnings: Beats Expectations

CTMX

Simply Wall St.

15 days ago

CytomX Therapeutics Third Quarter 2024 Earnings: Beats Expectations

CTMX

Thomson Reuters StreetEvents

16 days ago

Q3 2024 CytomX Therapeutics Inc Earnings Call

CTMX

GuruFocus.com

16 days ago

CytomX Therapeutics Inc (CTMX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

CTMX

Zacks

16 days ago

CytomX Therapeutics (CTMX) Q3 Earnings and Revenues Top Estimates

CTMX

Associated Press Finance

16 days ago

CytomX Therapeutics: Q3 Earnings Snapshot

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CTMX

GlobeNewswire

16 days ago

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CTMX

GuruFocus.com

18 days ago

Earnings To Watch: CytomX Therapeutics Inc (CTMX) Reports Q3 2024 Result

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

CTMX

GlobeNewswire

24 days ago

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

CTMX

GlobeNewswire

2 months ago

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

CytomX Therapeutics to Present at Upcoming September Investor Conferences

CTMX

GlobeNewswire

3 months ago

CytomX Therapeutics to Present at Upcoming September Investor Conferences

CytomX Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

CTMX

Simply Wall St.

3 months ago

CytomX Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

CTMX

Associated Press Finance

3 months ago

CytomX Therapeutics: Q2 Earnings Snapshot

CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

CTMX

GlobeNewswire

3 months ago

CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

CTMX

GlobeNewswire

4 months ago

CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

CTMX

Insider Monkey

4 months ago

CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now?

CTMX

Simply Wall St.

4 months ago

CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 47% of the company

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

CTMX

GlobeNewswire

5 months ago

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

CTMX

GlobeNewswire

5 months ago

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

CTMX

Simply Wall St.

6 months ago

Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

CTMX

GlobeNewswire

6 months ago

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

CytomX Therapeutics Announces New Employment Inducement Grants

CTMX

GlobeNewswire

6 months ago

CytomX Therapeutics Announces New Employment Inducement Grants

CTMX

Insider Monkey

6 months ago

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript

CTMX

MT Newswires

6 months ago

BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating

CTMX

Thomson Reuters StreetEvents

6 months ago

Q1 2024 CytomX Therapeutics Inc Earnings Call

CTMX

MT Newswires

6 months ago

Wedbush Upgrades CytomX Therapeutics to Outperform From Neutral, Adjusts Price Target to $8 From $3

CTMX

GuruFocus.com

6 months ago

CytomX Therapeutics Inc (CTMX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

CTMX

Associated Press Finance

7 months ago

CytomX Therapeutics: Q1 Earnings Snapshot

CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

CTMX

GlobeNewswire

7 months ago

CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

CTMX

GlobeNewswire

7 months ago

CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)

CTMX

GlobeNewswire

7 months ago

CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)

CTMX

MT Newswires

7 months ago

Jefferies Upgrades CytomX Therapeutics to Buy, Price Target at $8

CTMX

Zacks

7 months ago

CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

CTMX

GlobeNewswire

7 months ago

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

CTMX

Simply Wall St.

7 months ago

Here's Why We're Not Too Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Situation

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

CTMX

GlobeNewswire

8 months ago

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CTMX

GlobeNewswire

8 months ago

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

CTMX

GlobeNewswire

8 months ago

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CTMX

GlobeNewswire

8 months ago

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

CTMX

Simply Wall St.

8 months ago

CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

CTMX

Insider Monkey

8 months ago

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript

CTMX

Thomson Reuters StreetEvents

8 months ago

Q4 2023 CytomX Therapeutics Inc Earnings Call

CTMX

GuruFocus.com

8 months ago

CytomX Therapeutics Inc (CTMX) Reports 2023 Financial Results and Provides Pipeline Update

CTMX

Zacks

8 months ago

CytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

CTMX

GlobeNewswire

8 months ago

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

CTMX

GlobeNewswire

9 months ago

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

CTMX

Zacks

9 months ago

CytomX (CTMX) to Report Q4 Earnings: Here's What to Expect

CytomX Therapeutics to Present at Upcoming March Investor Conferences

CTMX

GlobeNewswire

9 months ago

CytomX Therapeutics to Present at Upcoming March Investor Conferences

CTMX

Simply Wall St.

9 months ago

CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) largest shareholders are retail investors with 50% ownership, institutions own 29%

LiveOne (Nasdaq: LVO) Launches "Splitmind Radio" Exclusively on Slacker Radio

CTMX

NewMediaWire

10 months ago

LiveOne (Nasdaq: LVO) Launches "Splitmind Radio" Exclusively on Slacker Radio

Marine Products Corporation (NYSE:MPX) Q4 2023 Earnings Call Transcript

CTMX

Insider Monkey

10 months ago

Marine Products Corporation (NYSE:MPX) Q4 2023 Earnings Call Transcript

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

CTMX

PR Newswire

10 months ago

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

BNY Mellon High Yield Strategies Fund Declares Dividend

CTMX

Business Wire

10 months ago

BNY Mellon High Yield Strategies Fund Declares Dividend

Southern States Bancshares Inc (SSBK) Reports Mixed Q4 Earnings Amid Interest Rate Challenges

CTMX

GuruFocus.com

10 months ago

Southern States Bancshares Inc (SSBK) Reports Mixed Q4 Earnings Amid Interest Rate Challenges

Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why

CTMX

Zacks

10 months ago

Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why

Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why

CTMX

Zacks

10 months ago

Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

CTMX

GlobeNewswire

10 months ago

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

Gran Tierra Energy Inc. Announces Strong Reserves Replacement and Meaningful Reserves Growth in 2023

CTMX

GlobeNewswire

10 months ago

Gran Tierra Energy Inc. Announces Strong Reserves Replacement and Meaningful Reserves Growth in 2023

Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal

CTMX

Zacks

10 months ago

Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal

Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why

CTMX

Zacks

10 months ago

Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

CTMX

Zacks

10 months ago

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck

CTMX

PR Newswire

10 months ago

Byrna Technologies Partners with Leading Multi-Media Personality Glenn Beck

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

CTMX

Zacks

10 months ago

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates

CTMX

Zacks

10 months ago

Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

CTMX

Simply Wall St.

10 months ago

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

Genetron Health to Hold Extraordinary General Meeting of Shareholders

CTMX

GlobeNewswire

10 months ago

Genetron Health to Hold Extraordinary General Meeting of Shareholders

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

CTMX

Business Wire

10 months ago

RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS

QuickLogic (QUIK) Is a Great Choice for 'Trend' Investors, Here's Why

CTMX

Zacks

10 months ago

QuickLogic (QUIK) Is a Great Choice for 'Trend' Investors, Here's Why

Innodata to Participate in Needham's 26th Annual Growth Conference

CTMX

ACCESSWIRE

10 months ago

Innodata to Participate in Needham's 26th Annual Growth Conference

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

CTMX

Simply Wall St.

10 months ago

At US$3.06, Is MYT Netherlands Parent B.V. (NYSE:MYTE) Worth Looking At Closely?

Leftovers: Dunkin’ muscles into protein powder | Danone whips up International Delight cold foam creamer

CTMX

Food Dive

a year ago

Leftovers: Dunkin’ muscles into protein powder | Danone whips up International Delight cold foam creamer

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CTMX

PR Newswire

a year ago

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

FARO Successfully Completes SOC 2 Type II Audit

CTMX

PR Newswire

a year ago

FARO Successfully Completes SOC 2 Type II Audit

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

CTMX

GlobeNewswire

a year ago

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

Does Marine Products (NYSE:MPX) Deserve A Spot On Your Watchlist?

CTMX

Simply Wall St.

a year ago

Does Marine Products (NYSE:MPX) Deserve A Spot On Your Watchlist?

Should You Invest in Bluebird Bio Right Now?

CTMX

Motley Fool

a year ago

Should You Invest in Bluebird Bio Right Now?

CTMX

Business Wire

a year ago

Stratasys Adopts Limited Duration Shareholder Rights Plan with Enhanced Shareholder Protections

CTMX

Zacks Small Cap Research

a year ago

XFOR: Update on Phase 2 CN Trial at ASH 2023

CTMX

Simply Wall St.

a year ago

Those who invested in Escalade (NASDAQ:ESCA) a year ago are up 110%

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

CTMX

GlobeNewswire

a year ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

CTMX

PR Newswire

a year ago

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

The five-year returns have been massive for Innodata (NASDAQ:INOD) shareholders despite underlying losses increasing

CTMX

Simply Wall St.

a year ago

The five-year returns have been massive for Innodata (NASDAQ:INOD) shareholders despite underlying losses increasing

Calculating The Intrinsic Value Of TrueCar, Inc. (NASDAQ:TRUE)

CTMX

Simply Wall St.

a year ago

Calculating The Intrinsic Value Of TrueCar, Inc. (NASDAQ:TRUE)

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

CTMX

GlobeNewswire

a year ago

X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023

Alto Ingredients, Inc. Extends Term Loan Commitment Period

CTMX

GlobeNewswire

a year ago

Alto Ingredients, Inc. Extends Term Loan Commitment Period

MYR Group Inc. to Attend Goldman Sachs Energy, CleanTech & Utilities Conference in January

CTMX

GlobeNewswire

a year ago

MYR Group Inc. to Attend Goldman Sachs Energy, CleanTech & Utilities Conference in January

L.B. Foster to Present at Sidoti and Singular Conferences; Updated Corporate Investor Presentation to be Posted Online

CTMX

GlobeNewswire

a year ago

L.B. Foster to Present at Sidoti and Singular Conferences; Updated Corporate Investor Presentation to be Posted Online

Adaptimmune Receives Transfer of IND for Lete-cel Program

CTMX

Newsfile

a year ago

Adaptimmune Receives Transfer of IND for Lete-cel Program

CTMX

Business Wire

a year ago

Western Asset Mortgage Opportunity Fund Inc. Announces Financial Position as of September 30, 2023

CTMX

Retail Dive

a year ago

Allbirds begins selling on Amazon

Mondee Announces Acquisition of Leading AI Company Purplegrids

CTMX

Business Wire

a year ago

Mondee Announces Acquisition of Leading AI Company Purplegrids

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

CTMX

GlobeNewswire

a year ago

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023

CTMX

GlobeNewswire

a year ago

Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023

CTMX

Associated Press Finance

a year ago

Sprott: Q3 Earnings Snapshot

Sprott Announces Third Quarter 2023 Results

CTMX

GlobeNewswire

a year ago

Latest CytomX Therapeutics Inc. (CTMX) News on November 24, 2024

Share on Social Networks: